LILRB3 suppresses immunity in glioma and is associated with poor prognosis

Qiyuan Zhuang; Ying Liu; Hanze Wang; Ziyang Lin; Li Sun; Yue Liu; Yingying Lyu; Liang Chen; Hui Yang; Ying Mao

doi:10.1002/ctm2.1396

LILRB3 suppresses immunity in glioma and is associated with poor prognosis

Clin Transl Med. 2023 Oct;13(10):e1396. doi: 10.1002/ctm2.1396.

Authors

Qiyuan Zhuang¹, Ying Liu², Hanze Wang³, Ziyang Lin¹, Li Sun¹, Yue Liu¹, Yingying Lyu¹, Liang Chen^{1

4

5

6}, Hui Yang^{1

3

4

5

6}, Ying Mao^{1

4

5

6}

Affiliations

¹ Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, P. R. China.
² Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
³ Institute for Translational Brain Research, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
⁴ National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
⁵ Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai Clinical Medical Center of Neurosurgery, Neurosurgical Institute of Fudan University, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
⁶ State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, P. R. China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antigens, CD
Brain Neoplasms* / genetics
Glioma* / genetics
Humans
Prognosis
Receptors, Immunologic

Substances

LILRB3 protein, human
Receptors, Immunologic
Antigens, CD